MedPath

西南药业股份有限公司

Ownership
-
Established
2015-01-08
Employees
-
Market Cap
-
Website
http://www.swp.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

495

NMPA:495

Drug Approvals

Oxycodone Hydrochloride Prolonged-release Tablets

Product Name
盐酸羟考酮缓释片
Approval Number
国药准字H20249069
Approval Date
Oct 16, 2024
NMPA

Valacyclovir Hydrochloride Capsules

Product Name
盐酸伐昔洛韦胶囊
Approval Number
国药准字H20093373
Approval Date
Apr 8, 2024
NMPA

Citalopram Hydrobromide Tablets

Product Name
氢溴酸西酞普兰片
Approval Number
国药准字H20090083
Approval Date
Jan 23, 2024
NMPA

Cefalexin Capsules

Product Name
头孢氨苄胶囊
Approval Number
国药准字H20084360
Approval Date
Jul 5, 2023
NMPA

Cefuroxime Sodium for Injection

Product Name
注射用头孢呋辛钠
Approval Number
国药准字H20183120
Approval Date
May 9, 2023
NMPA

Cefuroxime Sodium for Injection

Product Name
注射用头孢呋辛钠
Approval Number
国药准字H20183119
Approval Date
May 9, 2023
NMPA

Digestive Enzyme Tablets

Product Name
消化酶片
Approval Number
国药准字H20080320
Approval Date
May 9, 2023
NMPA

Simvastatin Tablets

Product Name
辛伐他汀片
Approval Number
国药准字H20123419
Approval Date
Oct 28, 2022
NMPA

Amoxicillin Capsules

Product Name
阿莫西林胶囊
Approval Number
国药准字H20083608
Approval Date
Sep 7, 2022
NMPA

Amoxicillin Capsules

Product Name
阿莫西林胶囊
Approval Number
国药准字H20073710
Approval Date
Sep 7, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 50
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.